speb/financial-data huggingface dataset:
Financial ratios for CLU.AX — annual report dated 2023-06-30
Total revenue: 26064900.662251655
Gross profit: 14923841.059602648
Operating income: -15120529.801324503
Net income: -12721854.304635761
Capital expenditures: 7947.019867549669
Depreciation & amortization: 2204635.7615894037
Net tangible assets: 5235761.589403974
Owner earnings: -10525165.562913908
Return on net tangible assets (%): -201.02453832532254
Buffett classification: The Gruesome
Stock price: 0.06622516556291391
Shares outstanding: 416973515
Book value: 11727814.569536423
P/B ratio: 2.354585323846632
Market cap (USD): 27614140.066225167
Debt to equity: 0.022079168784234007
Current ratio: 1.9987388069113383
Quick ratio: 1.9987388069113383
Interest coverage ratio: -992.6956521739131
COGS to revenue (%): 42.743533716144114
SG&A to revenue (%): 106.80928908989277
Free cash flow (dilution-adjusted): -11852317.880794702
Buyback yield (%): 1.3597985953616263
Retained earnings: -34447019.867549665
Receivables turnover: 116.44378698224851
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -125.35412320193258
FCF margin (%): -45.472330911123535
Revenue growth (%): 10.301856174373505
Rule of 40 score: -35.17047473675003
Financial ratios for CLU.AX — annual report dated 2024-06-30
Total revenue: 19978000
Gross profit: 11649333.333333334
Operating income: -11190666.666666666
Net income: -8956666.666666666
Capital expenditures: 3333.3333333333335
Depreciation & amortization: 3149333.3333333335
Net tangible assets: -384000
Owner earnings: -5810666.666666665
Buffett classification: The Gruesome
Stock price: 0.02666666666666667
Shares outstanding: 416973515
Book value: 3177333.333333333
P/B ratio: 3.4995678976080575
Market cap (USD): 11119293.733333334
Debt to equity: 0.016995383969785987
Current ratio: 0.9531835205992509
Quick ratio: 0.9531835205992509
Interest coverage ratio: -1526
COGS to revenue (%): 41.689191443921644
SG&A to revenue (%): 98.56175125971903
Free cash flow (dilution-adjusted): -6590000
Buyback yield (%): 0
Retained earnings: -43633333.333333336
Receivables turnover: 79.69946808510639
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -324.42984151526866
FCF margin (%): -32.986284913404745
Revenue growth (%): -23.35286345850907
Rule of 40 score: -56.339148371913815
Financial ratios for CNB.AX — annual report dated 2021-06-30
Operating income: -3094622.5563909775
Net income: 279234.5864661654
Capital expenditures: 48296.240601503756
Depreciation & amortization: 23686.466165413534
Net tangible assets: 7968512.030075188
Owner earnings: 254624.81203007518
Return on net tangible assets (%): 3.1953871823127895
Buffett classification: The Gruesome
Stock price: 0.2556390977443609
P/E ratio: 252.78757118007874
Shares outstanding: 276119864
Book value: 7968512.030075188
P/B ratio: 8.858245132321096
Market cap (USD): 70587032.90225564
Debt to equity: 0.0008589258416657065
Current ratio: 7.740869375748993
Quick ratio: 7.740869375748993
Effective tax rate (%): 0
Interest coverage ratio: -399.3642538327189
Free cash flow (dilution-adjusted): 441536.0902255639
Buyback yield (%): 0.27738912351059075
Retained earnings: -6541328.571428571
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.64862655189693
Rule of 40 score: 0
Financial ratios for CNB.AX — annual report dated 2022-06-30
Operating income: -6739420
Net income: -5666546.206896552
Capital expenditures: 784375.8620689656
Depreciation & amortization: 180665.5172413793
Net tangible assets: 16225011.724137932
Owner earnings: -6270256.551724138
Return on net tangible assets (%): -38.64562108387191
Buffett classification: The Gruesome
Stock price: 0.6206896551724138
Shares outstanding: 276119864
Book value: 16225011.724137932
P/B ratio: 10.562996568898924
Market cap (USD): 171384743.1724138
Debt to equity: 0.0027135201687543543
Current ratio: 7.407869224717153
Quick ratio: 7.407869224717153
Interest coverage ratio: -1264.6769768344764
Free cash flow (dilution-adjusted): -6435279.310344827
Buyback yield (%): 0.45878948024141025
Retained earnings: -11666523.448275862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.88460854251838
Rule of 40 score: 0
Financial ratios for CNB.AX — annual report dated 2023-06-30
Operating income: -8464222.51655629
Net income: -8101840.397350993
Capital expenditures: 125790.06622516556
Net tangible assets: 20932276.821192052
Owner earnings: -8227630.4635761585
Return on net tangible assets (%): -39.30595096681705
Buffett classification: The Gruesome
Stock price: 0.695364238410596
Shares outstanding: 276119864
Book value: 20932276.821192052
P/B ratio: 9.17262276724769
Market cap (USD): 192003878.94039735
Debt to equity: 0.0005919120185063544
Current ratio: 9.231306823311684
Quick ratio: 9.231306823311684
Interest coverage ratio: -1368.8525222234123
Free cash flow (dilution-adjusted): -7859091.390728476
Buyback yield (%): 0.37273874446269983
Retained earnings: -19304793.377483442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.96222826001142
Rule of 40 score: 0
Financial ratios for CNB.AX — annual report dated 2024-06-30
Operating income: -8601354.666666666
Net income: -8057562.666666667
Capital expenditures: 2940786.6666666665
Net tangible assets: 17851017.333333332
Owner earnings: -10998349.333333334
Return on net tangible assets (%): -61.61189095254554
Buffett classification: The Gruesome
Stock price: 0.32
Shares outstanding: 276119864
Book value: 17851017.333333332
P/B ratio: 4.949765877769208
Market cap (USD): 88358356.48
Debt to equity: 0.0024499444027951947
Current ratio: 4.236672960034509
Quick ratio: 4.236672960034509
Interest coverage ratio: -778.3092236230922
Free cash flow (dilution-adjusted): -11574725.333333334
Buyback yield (%): 0.005304157810730101
Retained earnings: -27510045.333333332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.27474521001795
Rule of 40 score: 0
Financial ratios for CRI.AX — annual report dated 2021-06-30
Operating income: -8858519.54887218
Net income: -8834645.864661654
Capital expenditures: 2691127.819548872
Depreciation & amortization: 20539.0977443609
Net tangible assets: 8659866.165413534
Owner earnings: -11505234.586466165
Return on net tangible assets (%): -132.85695606263167
Buffett classification: The Gruesome
Stock price: 0.11278195488721804
Shares outstanding: 3030806096
Book value: 8659866.165413534
P/B ratio: 39.4717689467496
Market cap (USD): 341820236.39097744
Debt to equity: 0
Current ratio: 2.4706545675303104
Quick ratio: 2.4706545675303104
Interest coverage ratio: -454.7740379048133
Free cash flow (dilution-adjusted): -8396717.293233082
Buyback yield (%): 0.24937788035912675
Retained earnings: -69308795.4887218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -99.27710033231595
Rule of 40 score: 0
Financial ratios for CRI.AX — annual report dated 2022-06-30
Operating income: -9087944.137931034
Net income: -12246371.724137932
Capital expenditures: 903740
Depreciation & amortization: 56072.41379310345
Net tangible assets: 6182945.517241379
Owner earnings: -13094039.310344828
Return on net tangible assets (%): -211.7767215291094
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 3030806096
Book value: 6182945.517241379
P/B ratio: 10.141822024119516
Market cap (USD): 62706333.02068965
Debt to equity: 0.007594081651296431
Current ratio: 5.47387202837704
Quick ratio: 5.47387202837704
Interest coverage ratio: -407.9727244582043
Free cash flow (dilution-adjusted): -13772632.413793104
Buyback yield (%): 0.7503284367156691
Retained earnings: -75819266.89655173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -140.78586551478298
Rule of 40 score: 0
Financial ratios for CRI.AX — annual report dated 2023-06-30
Operating income: -6093529.8013245035
Net income: -6034472.847682119
Capital expenditures: 4849.6688741721855
Depreciation & amortization: 50213.24503311258
Net tangible assets: 2052848.3443708608
Owner earnings: -5989109.2715231795
Return on net tangible assets (%): -291.7463088759569
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 3030806096
Book value: 2052848.344370861
P/B ratio: 9.777421505445025
Market cap (USD): 20071563.549668875
Debt to equity: 0.011091679756216607
Current ratio: 2.6244253041716554
Quick ratio: 2.6244253041716554
Interest coverage ratio: -338.55434542644787
Free cash flow (dilution-adjusted): -6156001.324503311
Buyback yield (%): 0.7767438514482914
Retained earnings: -78841053.64238411
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -265.869876404371
Rule of 40 score: 0
Financial ratios for CRI.AX — annual report dated 2024-06-30
Operating income: -5136620
Net income: -4218238
Capital expenditures: 4330
Depreciation & amortization: 61627.333333333336
Net tangible assets: 574005.3333333334
Owner earnings: -4160940.6666666665
Return on net tangible assets (%): -724.8958197833236
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 3030806096
Book value: 574005.3333333335
P/B ratio: 70.40134577146785
Market cap (USD): 40410747.94666667
Debt to equity: 0.16407629197405826
Current ratio: 1.0323893518236928
Quick ratio: 1.0323893518236928
Interest coverage ratio: -281.14026125665913
Free cash flow (dilution-adjusted): -3101506
Buyback yield (%): 0.3407608297221796
Retained earnings: -83584898.66666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -821.1978619884784
Rule of 40 score: 0
Financial ratios for CRWD — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.16
Shares outstanding: 1018259280
Market cap (USD): 45984589084.799995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRWD — annual report dated 2023-01-31
Total revenue: 2241236000
Gross profit: 1640005000
Operating income: -190112000
Net income: -182285000
Capital expenditures: 235019000
Operating cash flow: 941007000
Depreciation & amortization: 93810000
Net tangible assets: 946107000
Owner earnings: -323494000
Return on net tangible assets (%): -34.19211569093136
Buffett classification: The Gruesome
Stock price: 26.48
Shares outstanding: 1018259280
Book value: 1487434000
P/B ratio: 18.127530858108663
Market cap (USD): 26963505734.4
Debt to equity: 0.5268253919165489
Current ratio: 1.7260041383129643
Quick ratio: 1.7260041383129643
Interest coverage ratio: -7.508669378727438
COGS to revenue (%): 26.825867512390484
R&D to revenue (%): 27.144129400027484
SG&A to revenue (%): 54.51246544317511
Free cash flow (dilution-adjusted): 148066000
Buyback yield (%): 0
Retained earnings: -1148163000
Receivables turnover: 3.579214316627301
Capitalized R&D asset: 608364000
ROCI (R&D-adjusted, %): 6.111011528626435
FCF margin (%): 6.606443944323578
Rule of 40 score: 6.606443944323578
Financial ratios for CRWD — annual report dated 2024-01-31
Total revenue: 3055555000
Gross profit: 2296626000
Operating income: -19141000
Net income: 73439000
Capital expenditures: 176529000
Operating cash flow: 1166207000
Depreciation & amortization: 145254000
Net tangible assets: 1551391000
Owner earnings: 42164000
Return on net tangible assets (%): 2.7178190411056917
Buffett classification: The Gruesome
Stock price: 73.13
P/E ratio: 1013.9748791023842
Shares outstanding: 1018259280
Book value: 2337089000
P/B ratio: 31.86241565742682
Market cap (USD): 74465301146.4
Debt to equity: 0.3392570843472371
Current ratio: 1.763743016573369
Quick ratio: 1.763743016573369
Effective tax rate (%): 30.502219151895982
Interest coverage ratio: -0.7431666407827302
COGS to revenue (%): 24.837680879578343
R&D to revenue (%): 25.537717370494068
SG&A to revenue (%): 50.2510345910972
Free cash flow (dilution-adjusted): 280430000
Buyback yield (%): 0
Retained earnings: -1058836000
Receivables turnover: 3.581686896689153
Capitalized R&D asset: 1187922880
ROCI (R&D-adjusted, %): 5.80638799217491
Rosenberg metric: 1.0793225766153158
FCF margin (%): 9.177710759583775
Revenue growth (%): 36.33347849133246
Rule of 40 score: 45.51118925091623
Financial ratios for CRWD — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.22
Shares outstanding: 1018259280
Market cap (USD): 75575203761.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRWD — annual report dated 2025-01-31
Total revenue: 3953624000
Gross profit: 2963452000
Operating income: -116400000
Net income: -12566000
Capital expenditures: 254852000
Operating cash flow: 1381727000
Depreciation & amortization: 213956000
Net tangible assets: 2233575000
Owner earnings: -53462000
Return on net tangible assets (%): -2.3935618906909326
Buffett classification: The Gruesome
Stock price: 99.52
Shares outstanding: 1018259280
Book value: 3318917000
P/B ratio: 30.5332021094833
Market cap (USD): 101337163545.59999
Debt to equity: 0.23769832147052788
Current ratio: 1.766326692766646
Quick ratio: 1.766326692766646
Effective tax rate (%): 121.45686770029369
Interest coverage ratio: -4.424005168940747
COGS to revenue (%): 25.04466787939369
R&D to revenue (%): 27.205090823001882
SG&A to revenue (%): 50.69437559059738
Free cash flow (dilution-adjusted): 206515000
Buyback yield (%): 0
Retained earnings: -1120540000
Receivables turnover: 3.503234198503585
Capitalized R&D asset: 1799160850
ROCI (R&D-adjusted, %): 1.9569567576366194
Rosenberg metric: 0.854555636861335
FCF margin (%): 5.223435511318224
Revenue growth (%): 29.391354434791715
Rule of 40 score: 34.61478994610994
Financial ratios for CRWD — quarterly report dated 2025-01-31
Total revenue: 1058538000
Gross profit: 784548000
Operating income: -85301000
Net income: -92282000
Capital expenditures: 87211000
Operating cash flow: 345722000
Depreciation & amortization: 57440000
Net tangible assets: 2233575000
Owner earnings: -122053000
Return on net tangible assets (%): -5.464468397076436
Buffett classification: The Gruesome
Stock price: 99.52
Shares outstanding: 1018259280
Book value: 3318917000
P/B ratio: 30.5332021094833
Market cap (USD): 101337163545.59999
Debt to equity: 0.23769832147052788
Current ratio: 1.766326692766646
Quick ratio: 1.766326692766646
Interest coverage ratio: -12.800270108043216
COGS to revenue (%): 25.883813334996002
R&D to revenue (%): 29.771439475956463
SG&A to revenue (%): 52.40312582070743
Free cash flow (dilution-adjusted): -31723000
Buyback yield (%): 0
Retained earnings: -1120540000
Receivables turnover: 0.9379512371473837
Capitalized R&D asset: 315142000
ROCI (R&D-adjusted, %): 2.2462397274616146
FCF margin (%): -2.99686926685674
Rule of 40 score: -2.99686926685674
Financial ratios for CRWD — quarterly report dated 2025-04-30
Total revenue: 1103434000
Gross profit: 815559000
Operating income: -118713000
Net income: -104264000
Capital expenditures: 85751000
Operating cash flow: 384107000
Depreciation & amortization: 64057000
Net tangible assets: 2412106000
Owner earnings: -125958000
Return on net tangible assets (%): -5.221909816566934
Buffett classification: The Gruesome
Stock price: 107.22
Shares outstanding: 1018259280
Book value: 3491014000
P/B ratio: 31.27393932009439
Market cap (USD): 109177760001.6
Debt to equity: 0.22497704105454747
Current ratio: 1.8494242557731313
Quick ratio: 1.8494242557731313
Interest coverage ratio: -17.678778853313478
COGS to revenue (%): 26.08900940155913
R&D to revenue (%): 29.99055675282799
SG&A to revenue (%): 54.67893865876889
Free cash flow (dilution-adjusted): 33258000
Buyback yield (%): 0
Retained earnings: -1188314000
Receivables turnover: 1.364464185464465
Capitalized R&D asset: 542071140
ROCI (R&D-adjusted, %): -0.05255941490678721
Rosenberg metric: 0.0984032594830267
FCF margin (%): 3.014045244210347
Revenue growth (%): 4.241321520814558
Rule of 40 score: 7.255366765024904
Financial ratios for CRWD — quarterly report dated 2025-07-31
Total revenue: 1168952000
Gross profit: 858669000
Operating income: -112979000
Net income: -77645000
Capital expenditures: 30497000
Operating cash flow: 332832000
Depreciation & amortization: 68038000
Net tangible assets: 2725497000
Owner earnings: -40104000
Return on net tangible assets (%): -1.4714380533165143
Buffett classification: The Gruesome
Stock price: 113.64
Shares outstanding: 1018259280
Book value: 3794691000
P/B ratio: 30.49391494042598
Market cap (USD): 115714984579.2
Debt to equity: 0.21359525716323147
Current ratio: 1.8798822073351136
Quick ratio: 1.8798822073351136
Interest coverage ratio: -16.558551956617325
COGS to revenue (%): 26.543690416715144
R&D to revenue (%): 29.656307530163772
SG&A to revenue (%): 53.46498401987421
Free cash flow (dilution-adjusted): -8050000
Buyback yield (%): 0
Retained earnings: -1265989000
Receivables turnover: 1.3185299986351695
Capitalized R&D asset: 672385280
ROCI (R&D-adjusted, %): -1.4991273473054845
Rosenberg metric: 0.13027081583193825
FCF margin (%): -0.6886510310089722
Revenue growth (%): 5.93764556828954
Rule of 40 score: 5.248994537280567
Financial ratios for CRWD — quarterly report dated 2025-10-31
Total revenue: 1234244000
Gross profit: 926439000
Operating income: -69443000
Net income: -33988000
Capital expenditures: 83395000
Operating cash flow: 397541000
Depreciation & amortization: 71849000
Net tangible assets: 2519165000
Owner earnings: -45534000
Return on net tangible assets (%): -1.8075036768135475
Buffett classification: The Gruesome
Stock price: 135.75
Shares outstanding: 1018259280
Book value: 4059017000
P/B ratio: 34.05472242663679
Market cap (USD): 138228697260
Debt to equity: 0.20153795857469925
Current ratio: 1.8109644864641885
Quick ratio: 1.8109644864641885
Interest coverage ratio: -10.019189150194777
COGS to revenue (%): 24.93874792990689
R&D to revenue (%): 28.160072076509994
SG&A to revenue (%): 52.52753912516488
Free cash flow (dilution-adjusted): 15405000
Buyback yield (%): 0
Retained earnings: -1299986000
Receivables turnover: 1.2182652332013313
Capitalized R&D asset: 689037140
ROCI (R&D-adjusted, %): -0.9015299629950713
Rosenberg metric: 0.1954896327321818
FCF margin (%): 1.2481324600322141
Revenue growth (%): 5.585515915110287
Rule of 40 score: 6.833648375142501
Financial ratios for CRWD — annual report dated 2026-01-31
Total revenue: 4812005000
Gross profit: 3593076000
Operating income: -293292000
Net income: -161165000
Capital expenditures: 302108000
Operating cash flow: 1612349000
Depreciation & amortization: 281451000
Net tangible assets: 2928394000
Owner earnings: -181822000
Return on net tangible assets (%): -6.208932267993992
Buffett classification: The Gruesome
Stock price: 110.35
Shares outstanding: 1018259280
Book value: 4472605000
P/B ratio: 25.122923117064882
Market cap (USD): 112364911548
Debt to equity: 0.18335556124450963
Current ratio: 1.773130630716755
Quick ratio: 1.773130630716755
Interest coverage ratio: -10.466864137611077
COGS to revenue (%): 25.33100027950927
R&D to revenue (%): 28.77740151974073
SG&A to revenue (%): 51.98660433644603
Free cash flow (dilution-adjusted): 144811000
Buyback yield (%): 0
Retained earnings: -1283042000
Receivables turnover: 3.5334480307582954
Capitalized R&D asset: 2362918560
ROCI (R&D-adjusted, %): 0.12144811709959183
Rosenberg metric: 0.5853771010620248
FCF margin (%): 3.0093692753852084
Revenue growth (%): 21.711245176577236
Rule of 40 score: 24.720614451962444
Financial ratios for CRWD — quarterly report dated 2026-01-31
Total revenue: 1305375000
Gross profit: 993677000
Operating income: 13786000
Net income: 61461000
Capital expenditures: 102465000
Operating cash flow: 497869000
Depreciation & amortization: 77507000
Net tangible assets: 2928394000
Owner earnings: 36503000
Return on net tangible assets (%): 1.246519423274327
Capex to operating income (%): 743.254025823299
Buffett classification: The Gruesome
Stock price: 110.35
P/E ratio: 457.05777463757505
Shares outstanding: 1018259280
Book value: 4472605000
P/B ratio: 25.122923117064882
Market cap (USD): 112364911548
Debt to equity: 0.18335556124450963
Current ratio: 1.773130630716755
Quick ratio: 1.773130630716755
Effective tax rate (%): -6.2603734439834025
Interest coverage ratio: 1.8254766949152543
COGS to revenue (%): 23.87804270803409
R&D to revenue (%): 27.30318873886814
SG&A to revenue (%): 47.76267356123719
Free cash flow (dilution-adjusted): 104198000
Buyback yield (%): 0
Retained earnings: -1283042000
Receivables turnover: 0.9585348982702865
Capitalized R&D asset: 703677320
ROCI (R&D-adjusted, %): 0.26269903406953493
Rosenberg metric: 0.1934550183563315
FCF margin (%): 7.982227329311501
Revenue growth (%): 5.763123012953678
Rule of 40 score: 13.74535034226518
Financial ratios for CWST — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.42
Shares outstanding: 62621741
Market cap (USD): 5349149116.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWST — annual report dated 2022-12-31
Total revenue: 1085089000
Gross profit: 361972000
Operating income: 101443000
Net income: 53079000
Capital expenditures: 130360000
Operating cash flow: 217314000
Depreciation & amortization: 126351000
Net tangible assets: 131659000
Owner earnings: 49070000
Return on net tangible assets (%): 37.270524612825554
Capex to operating income (%): 128.5056632788857
Buffett classification: The Gruesome
Stock price: 79.31
P/E ratio: 93.5686482169973
Shares outstanding: 62621741
Book value: 497900000
P/B ratio: 9.974955369973891
Market cap (USD): 4966530278.71
Debt to equity: 1.322209278971681
Current ratio: 1.1682376126126126
Quick ratio: 1.0923817567567569
Effective tax rate (%): 29.195902142304515
Interest coverage ratio: 4.2763257735435465
COGS to revenue (%): 66.64126168452542
SG&A to revenue (%): 12.29567344245495
Free cash flow (dilution-adjusted): 78199000
Buyback yield (%): 0
Retained earnings: -171920000
Inventory turnover: 53.675549287410924
Receivables turnover: 10.755595424538589
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.977493187796621
FCF margin (%): 7.206689958150898
Rule of 40 score: 7.206689958150898
Financial ratios for CWST — annual report dated 2023-12-31
Total revenue: 1264542000
Gross profit: 432504000
Operating income: 102082000
Net income: 25399000
Capital expenditures: 153797000
Operating cash flow: 233092000
Depreciation & amortization: 170705000
Net tangible assets: 44692000
Owner earnings: 42307000
Return on net tangible assets (%): 94.66347444732838
Capex to operating income (%): 150.66025352167864
Buffett classification: The Gruesome
Stock price: 85.46
P/E ratio: 210.70333422024487
Shares outstanding: 62621741
Book value: 1021791000
P/B ratio: 5.237523119561632
Market cap (USD): 5351653985.86
Debt to equity: 1.0947013626074216
Current ratio: 1.528824706481435
Quick ratio: 1.4647813582540217
Effective tax rate (%): 31.437440950195704
Interest coverage ratio: 2.2880132687824997
COGS to revenue (%): 65.79757730466841
SG&A to revenue (%): 12.324383057265003
Free cash flow (dilution-adjusted): 69101000
Buyback yield (%): 0
Retained earnings: -146521000
Inventory turnover: 46.58928271459768
Receivables turnover: 7.883039404537039
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.523684177873733
FCF margin (%): 5.464508098584309
Revenue growth (%): 16.538090423919144
Rule of 40 score: 22.002598522503455
Financial ratios for CWST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 99.49
Shares outstanding: 62621741
Market cap (USD): 6230237012.09
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWST — annual report dated 2024-12-31
Total revenue: 1557283000
Gross profit: 529947000
Operating income: 106025000
Net income: 13536000
Capital expenditures: 201847000
Operating cash flow: 281355000
Depreciation & amortization: 234907000
Net tangible assets: 235105000
Owner earnings: 46596000
Return on net tangible assets (%): 19.819229705876097
Capex to operating income (%): 190.37679792501768
Buffett classification: The Gruesome
Stock price: 105.81
P/E ratio: 489.5099302016844
Shares outstanding: 62621741
Book value: 1550839000
P/B ratio: 4.272530169289011
Market cap (USD): 6626006415.21
Debt to equity: 0.7789274063909922
Current ratio: 1.9956754751608274
Quick ratio: 1.9255882362511674
Effective tax rate (%): 35.689851767388824
Interest coverage ratio: 1.7834014566617886
COGS to revenue (%): 65.9697691427955
SG&A to revenue (%): 12.24915445683283
Free cash flow (dilution-adjusted): 65662000
Buyback yield (%): 0
Retained earnings: -132985000
Inventory turnover: 47.696550443381774
Receivables turnover: 9.38591584949101
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.627575527302873
FCF margin (%): 4.216446207914682
Revenue growth (%): 23.149962595153028
Rule of 40 score: 27.36640880306771
Financial ratios for CWST — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 105.81
Shares outstanding: 62621741
Market cap (USD): 6626006415.21
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWST — quarterly report dated 2025-03-31
Total revenue: 417101000
Gross profit: 136601000
Operating income: 8601000
Net income: -4810000
Capital expenditures: 55259000
Operating cash flow: 50123000
Depreciation & amortization: 71500000
Net tangible assets: 177822000
Owner earnings: 11431000
Capex to operating income (%): 642.4718056039995
Buffett classification: The Gruesome
Stock price: 111.51
Shares outstanding: 62621741
Book value: 1546889000
P/B ratio: 4.514189666427262
Market cap (USD): 6982950338.91
Debt to equity: 0.7885142372852868
Current ratio: 1.9559366397759639
Quick ratio: 1.8656459337756774
Interest coverage ratio: 0.5741655540720961
COGS to revenue (%): 67.25205645634989
SG&A to revenue (%): 13.569854783373811
Free cash flow (dilution-adjusted): -10263000
Buyback yield (%): 0
Retained earnings: -137795000
Inventory turnover: 12.358313507798044
Receivables turnover: 2.3854107689228217
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.291117021528647
FCF margin (%): -2.4605551173456788
Rule of 40 score: -2.4605551173456788
Financial ratios for CWST — quarterly report dated 2025-06-30
Total revenue: 465334000
Gross profit: 157234000
Operating income: 25734000
Net income: 5208000
Capital expenditures: 66116000
Operating cash flow: 89525000
Depreciation & amortization: 77006000
Net tangible assets: 150047000
Owner earnings: 16098000
Return on net tangible assets (%): 10.72863835998054
Capex to operating income (%): 256.92080516048804
Buffett classification: The Gruesome
Stock price: 115.38
P/E ratio: 18154.011247688442
Shares outstanding: 62621741
Book value: 1554181000
P/B ratio: 4.648941453138341
Market cap (USD): 7225296476.58
Debt to equity: 0.7942498331918869
Current ratio: 1.6989678731310531
Quick ratio: 1.6138082628668402
Effective tax rate (%): 24.379265282416146
Interest coverage ratio: 1.642770507500798
COGS to revenue (%): 66.21050686173801
SG&A to revenue (%): 11.626057842324009
Free cash flow (dilution-adjusted): 20256000
Buyback yield (%): 0
Retained earnings: -132587000
Inventory turnover: 13.232262497852602
Receivables turnover: 2.451319601748933
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8625454374818795
FCF margin (%): 4.353002359595473
Revenue growth (%): 11.563865826262704
Rule of 40 score: 15.916868185858178
Financial ratios for CWST — quarterly report dated 2025-09-30
Total revenue: 485351000
Gross profit: 170051000
Operating income: 33951000
Net income: 9984000
Capital expenditures: 65847000
Operating cash flow: 93565000
Depreciation & amortization: 78829000
Net tangible assets: 142557000
Owner earnings: 22966000
Return on net tangible assets (%): 16.1100472091865
Capex to operating income (%): 193.94715914111512
Buffett classification: The Gruesome
Stock price: 94.88
P/E ratio: 572.293468125602
Shares outstanding: 62621741
Book value: 1567364000
P/B ratio: 3.790791919477543
Market cap (USD): 5941550786.08
Debt to equity: 0.7868325417707692
Current ratio: 1.51095259776395
Quick ratio: 1.429530699313671
Effective tax rate (%): 37.16803020767778
Interest coverage ratio: 2.1292568203198496
COGS to revenue (%): 64.96329460534747
SG&A to revenue (%): 11.785285288378926
Free cash flow (dilution-adjusted): 23770000
Buyback yield (%): 0
Retained earnings: -122603000
Inventory turnover: 13.060226990307347
Receivables turnover: 2.4416613424959377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1359457867020968
FCF margin (%): 4.897486561272151
Revenue growth (%): 4.301641401659883
Rule of 40 score: 9.199127962932035
Financial ratios for CWST — annual report dated 2025-12-31
Total revenue: 1836841000
Gross profit: 620236000
Operating income: 89182000
Net income: 7871000
Capital expenditures: 244262000
Operating cash flow: 329776000
Depreciation & amortization: 306835000
Net tangible assets: 157798000
Owner earnings: 70444000
Return on net tangible assets (%): 44.64188392755295
Capex to operating income (%): 273.8915924738176
Buffett classification: The Gruesome
Stock price: 97.94
P/E ratio: 779.2114488044721
Shares outstanding: 62621741
Book value: 1568709000
P/B ratio: 3.9096947321268636
Market cap (USD): 6133173313.54
Debt to equity: 0.7899023974491126
Current ratio: 1.2564766486788113
Quick ratio: 1.1736020850487578
Effective tax rate (%): 39.695065890285015
Interest coverage ratio: 1.4983283210967557
COGS to revenue (%): 66.23354988265179
SG&A to revenue (%): 12.20677238802923
Free cash flow (dilution-adjusted): 69816000
Buyback yield (%): 0
Retained earnings: -125114000
Inventory turnover: 49.94888533070575
Receivables turnover: 10.315390749601276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.963424230018768
FCF margin (%): 3.800873347230381
Revenue growth (%): 17.951650406509287
Rule of 40 score: 21.75252375373967
Financial ratios for CWST — quarterly report dated 2025-12-31
Total revenue: 469055000
Gross profit: 156250000
Operating income: 20796000
Net income: -2511000
Capital expenditures: 57040000
Operating cash flow: 96563000
Depreciation & amortization: 79535000
Net tangible assets: 157798000
Owner earnings: 19984000
Capex to operating income (%): 274.2835160607809
Buffett classification: The Gruesome
Stock price: 97.94
P/E ratio: 779.2114488044721
Shares outstanding: 62621741
Book value: 1568709000
P/B ratio: 3.9096947321268636
Market cap (USD): 6133173313.54
Debt to equity: 0.7899023974491126
Current ratio: 1.2564766486788113
Quick ratio: 1.1736020850487578
Interest coverage ratio: 1.6082282886087695
COGS to revenue (%): 66.69388451247723
SG&A to revenue (%): 12.006907505516411
Free cash flow (dilution-adjusted): 36053000
Buyback yield (%): 0
Retained earnings: -125114000
Inventory turnover: 12.843576795171819
Receivables turnover: 2.634134150998495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6910292467927417
FCF margin (%): 7.6863054439244864
Revenue growth (%): -3.3575700884514506
Rule of 40 score: 4.328735355473036
Financial ratios for DAN.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.36220472440944884
Shares outstanding: 231254326
Market cap (USD): 83761409.41732284
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAN.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -67043.38235294117
Operating income: -1352008.8235294116
Net income: -6692101.470588235
Capital expenditures: 393187.5
Operating cash flow: -1012577.9411764705
Depreciation & amortization: 104148.5294117647
Net tangible assets: 26861388.235294115
Owner earnings: -6981140.44117647
Return on net tangible assets (%): -25.98949979809199
Buffett classification: The Gruesome
Stock price: 0.2647058823529411
Shares outstanding: 231254326
Book value: 26861388.23529412
P/B ratio: 2.2788986137109988
Market cap (USD): 61214380.411764696
Debt to equity: 0.7085783913318833
Current ratio: 1.7135796333245672
Quick ratio: 1.7135796333245672
Interest coverage ratio: -0.24816337063344598
Free cash flow (dilution-adjusted): -1710533.088235294
Buyback yield (%): 0
Retained earnings: -57241919.11764705
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8483749217183005
Rule of 40 score: 0
Financial ratios for DAN.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -71004.54545454546
Operating income: -1610478.7878787878
Net income: -529225
Capital expenditures: 189909.84848484848
Operating cash flow: -1146109.8484848484
Depreciation & amortization: 85792.42424242424
Net tangible assets: 29219510.606060605
Owner earnings: -633342.4242424242
Return on net tangible assets (%): -2.1675326215458877
Buffett classification: The Gruesome
Stock price: 0.19696969696969696
Shares outstanding: 231254326
Book value: 29219510.606060605
P/B ratio: 1.5588931357975473
Market cap (USD): 45550094.515151516
Debt to equity: 0.6291541812789369
Current ratio: 1.652942730326568
Quick ratio: 1.652942730326568
Interest coverage ratio: -1.415384164687569
Free cash flow (dilution-adjusted): -1644731.8181818184
Buyback yield (%): 0
Retained earnings: -59556592.42424242
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.2864900377238793
Rule of 40 score: 0
Financial ratios for DAN.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.14074074074074072
Shares outstanding: 231254326
Market cap (USD): 32546905.140740737
Buyback yield (%): 0
Capitalized R&D asset: 14288.888888888889
Rule of 40 score: 0
Financial ratios for DAN.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -8755.244755244756
Operating income: -379561.5384615385
Net income: -1743827.972027972
Capital expenditures: 79973.42657342658
Operating cash flow: -340408.3916083916
Depreciation & amortization: 12436.363636363636
Net tangible assets: 20625476.223776225
Owner earnings: -1811365.034965035
Return on net tangible assets (%): -8.78217314990752
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 231254326
Book value: 20625476.223776225
P/B ratio: 1.0976853779616906
Market cap (USD): 22640283.664335668
Debt to equity: 1.175201989826486
Current ratio: 0.8911506680335788
Quick ratio: 0.8911506680335788
Interest coverage ratio: -0.21290191746776896
Free cash flow (dilution-adjusted): -450987.4125874126
Buyback yield (%): 0
Retained earnings: -62668698.6013986
Receivables turnover: 0
Capitalized R&D asset: 9573.555555555557
ROCI (R&D-adjusted, %): -0.8745903845699694
Rule of 40 score: 0
Financial ratios for DAN.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -26512.587412587414
Operating income: -1804554.5454545456
Net income: -7685817.482517483
Capital expenditures: 130367.13286713287
Operating cash flow: -1546030.06993007
Depreciation & amortization: 41032.167832167834
Net tangible assets: 20625476.223776225
Owner earnings: -7775152.447552448
Return on net tangible assets (%): -37.69683843027858
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 231254326
Book value: 20625476.223776225
P/B ratio: 1.0976853779616906
Market cap (USD): 22640283.664335668
Debt to equity: 1.175201989826486
Current ratio: 0.8911506680335788
Quick ratio: 0.8911506680335788
Interest coverage ratio: -0.28790873099329406
Free cash flow (dilution-adjusted): -1875251.048951049
Buyback yield (%): 0
Retained earnings: -62668698.6013986
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.1074403571387474
Rule of 40 score: 0
Financial ratios for DAN.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -2061.5384615384614
Operating income: -397607.6923076923
Net income: -2410614.6853146856
Capital expenditures: 24943.356643356645
Operating cash flow: -323700
Depreciation & amortization: 5700
Net tangible assets: 19436499.3006993
Owner earnings: -2429858.0419580424
Return on net tangible assets (%): -12.501521001112682
Buffett classification: The Gruesome
Stock price: 0.1118881118881119
Shares outstanding: 231254326
Book value: 19436499.300699297
P/B ratio: 1.3312381772970288
Market cap (USD): 25874609.902097907
Debt to equity: 1.2883713771300584
Current ratio: 0.11824429145399122
Quick ratio: 0.11824429145399122
Interest coverage ratio: -0.20505205470757182
Free cash flow (dilution-adjusted): -367572.7272727273
Buyback yield (%): 0
Retained earnings: -65086859.44055945
Receivables turnover: 0
Capitalized R&D asset: 106104.84382284382
ROCI (R&D-adjusted, %): -1.508842552978345
Rule of 40 score: 0
Financial ratios for DAN.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -6143.065693430656
Operating income: -537708.7591240875
Net income: -2575294.890510949
Capital expenditures: 26705.839416058392
Operating cash flow: -545294.1605839416
Depreciation & amortization: 9954.014598540145
Net tangible assets: 17746453.28467153
Owner earnings: -2592046.715328467
Return on net tangible assets (%): -14.605998583206162
Buffett classification: The Gruesome
Stock price: 0.11678832116788321
Shares outstanding: 231254326
Book value: 17746453.284671534
P/B ratio: 1.5218705429821466
Market cap (USD): 27007804.496350363
Debt to equity: 1.5869725547298623
Current ratio: 0.0896648406370656
Quick ratio: 0.0896648406370656
Interest coverage ratio: -0.2668028216607408
Free cash flow (dilution-adjusted): -606015.3284671532
Buyback yield (%): 0
Retained earnings: -70512673.72262773
Receivables turnover: 0
Capitalized R&D asset: 301976.22750242456
ROCI (R&D-adjusted, %): -1.9973259588004542
Rosenberg metric: -0.04025591219630614
Rule of 40 score: 0
Financial ratios for DAN.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -5819.4244604316555
Operating income: -367419.4244604317
Net income: -2984719.424460432
Capital expenditures: 26913.669064748203
Operating cash flow: -282158.273381295
Depreciation & amortization: 9575.539568345324
Net tangible assets: 14555410.071942447
Owner earnings: -3002057.5539568346
Return on net tangible assets (%): -20.62502903812867
Buffett classification: The Gruesome
Stock price: 0.17266187050359713
Shares outstanding: 231254326
Book value: 14555410.071942445
P/B ratio: 2.7432277271374783
Market cap (USD): 39928804.48920864
Debt to equity: 2.08597322462117
Current ratio: 0.07121138986202895
Quick ratio: 0.07121138986202895
Interest coverage ratio: -0.14199721351116223
Free cash flow (dilution-adjusted): -358092.80575539573
Buyback yield (%): 0
Retained earnings: -72482822.30215828
Receivables turnover: 0
Capitalized R&D asset: 256274.61502510513
ROCI (R&D-adjusted, %): -2.4840458040390323
Rosenberg metric: 0.0013828147566714
Rule of 40 score: 0
Financial ratios for DMII — annual report dated 2025-12-31
Total revenue: 0
Operating income: -1300498
Net income: 4187050
Capital expenditures: 0
Operating cash flow: -1018231
Net tangible assets: 487158973
Owner earnings: 4187050
Return on net tangible assets (%): 0.8594832964310399
Buffett classification: The Gruesome
Stock price: 9.9
P/E ratio: 150.61439438267993
Shares outstanding: 63700000
Book value: 487158973
P/B ratio: 1.2945055617399046
Market cap (USD): 630630000
Debt to equity: 0
Current ratio: 0.08654076260370135
Quick ratio: 0.08654076260370135
Free cash flow (dilution-adjusted): -1018231
Buyback yield (%): 0
Retained earnings: -17776196
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2576983804070794
Rule of 40 score: 0
Financial ratios for DMII — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -1047585
Net income: 4330608
Capital expenditures: 0
Operating cash flow: -314864
Net tangible assets: 487158973
Owner earnings: 4330608
Return on net tangible assets (%): 0.8889517057094214
Buffett classification: The Gruesome
Stock price: 9.9
P/E ratio: 150.61439438267993
Shares outstanding: 63700000
Book value: 487158973
P/B ratio: 1.2945055617399046
Market cap (USD): 630630000
Debt to equity: 0
Current ratio: 0.08654076260370135
Quick ratio: 0.08654076260370135
Free cash flow (dilution-adjusted): -314864
Buyback yield (%): 0
Retained earnings: -17776196
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2075827550974705
Rule of 40 score: 0
Financial ratios for DPAM.PA — annual report dated 2021-12-31
Capital expenditures: 43392.045454545456
Buffett classification: The Gruesome
Stock price: 377.8977272727273
Shares outstanding: 97800
Market cap (USD): 36958397.727272734
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPAM.PA — annual report dated 2022-12-31
Total revenue: 18333505.319148935
Gross profit: 13612444.680851065
Operating income: 5784176.595744682
Net income: 4498205.319148936
Capital expenditures: 1292227.6595744682
Operating cash flow: 6230313.829787235
Depreciation & amortization: 2157751.0638297875
Net tangible assets: 14007651.063829789
Owner earnings: 5363728.723404257
Return on net tangible assets (%): 38.29142158783741
Capex to operating income (%): 22.340736631816146
Buffett classification: The Great
Stock price: 385.5
P/E ratio: 8.381542709823043
Shares outstanding: 97800
Book value: 14245238.297872342
P/B ratio: 2.646631752424326
Market cap (USD): 37701900
Debt to equity: 0
Current ratio: 6.55486174818799
Quick ratio: 6.468017619159851
Effective tax rate (%): 25.43652028054108
COGS to revenue (%): 25.750998274000718
SG&A to revenue (%): 23.946651564293838
Free cash flow (dilution-adjusted): 4938086.170212766
Buyback yield (%): 0
Retained earnings: 4498205.319148936
Inventory turnover: 23.991463665163753
Receivables turnover: 9.684366600600049
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.78376708283558
FCF margin (%): 26.934762797679753
Rule of 40 score: 26.934762797679753
Financial ratios for DPAM.PA — annual report dated 2023-12-31
Total revenue: 20631616.666666668
Gross profit: 15616954.444444444
Operating income: 5711261.111111111
Net income: 4774075.555555555
Capital expenditures: 2305102.222222222
Operating cash flow: 8328904.444444444
Depreciation & amortization: 4105023.333333333
Net tangible assets: 15368297.777777778
Owner earnings: 6573996.666666666
Return on net tangible assets (%): 42.776348830073566
Capex to operating income (%): 40.36065200622163
Buffett classification: The Good
Stock price: 433.9111111111111
P/E ratio: 8.888947435547733
Shares outstanding: 97800
Book value: 15523103.333333336
P/B ratio: 2.73376436112109
Market cap (USD): 42436506.666666664
Debt to equity: 0
Current ratio: 5.985438836315301
Quick ratio: 5.913320292733768
Effective tax rate (%): 25.442852832045702
COGS to revenue (%): 24.305716334503867
SG&A to revenue (%): 22.299561272060597
Free cash flow (dilution-adjusted): 6023802.222222222
Buyback yield (%): 0
Retained earnings: 4774075.555555555
Inventory turnover: 22.50645043858993
Receivables turnover: 10.016585112184838
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.844257966268074
FCF margin (%): 29.196947188120927
Revenue growth (%): 12.535035212919194
Rule of 40 score: 41.73198240104012
Financial ratios for DPAM.PA — annual report dated 2024-12-31
Total revenue: 21675255.208333336
Gross profit: 16829059.375
Operating income: 7978305.208333334
Net income: 6390764.583333334
Capital expenditures: 1358282.2916666667
Operating cash flow: 10447475
Depreciation & amortization: 4446709.375
Net tangible assets: 16647367.708333334
Owner earnings: 9479191.666666668
Return on net tangible assets (%): 56.941084216705185
Capex to operating income (%): 17.024697052801915
Buffett classification: The Great
Stock price: 570.71875
P/E ratio: 8.733899210677386
Shares outstanding: 97800
Book value: 16766797.916666672
P/B ratio: 3.328977544037614
Market cap (USD): 55816293.75
Debt to equity: 0
Current ratio: 5.820361292702703
Quick ratio: 5.736526959296412
Effective tax rate (%): 25.576878800075605
Interest coverage ratio: 17688.621247113166
COGS to revenue (%): 22.35819503278628
SG&A to revenue (%): 20.450994305382313
Free cash flow (dilution-adjusted): 9089192.708333334
Buyback yield (%): 0
Retained earnings: 6390763.541666667
Inventory turnover: 15.278345911082214
Receivables turnover: 10.857561408314746
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.92673169163956
FCF margin (%): 41.933497995626254
Revenue growth (%): 5.058442867217553
Rule of 40 score: 46.991940862843805
Financial ratios for DPAM.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 16647367.708333334
Buffett classification: The Gruesome
Stock price: 570.71875
Shares outstanding: 97800
Book value: 16766797.916666672
P/B ratio: 3.328977544037614
Market cap (USD): 55816293.75
Debt to equity: 0
Current ratio: 5.820361292702703
Quick ratio: 5.736526959296412
Buyback yield (%): 0
Retained earnings: 6390763.541666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBON — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.9
Shares outstanding: 4726424
Market cap (USD): 146046501.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBON — annual report dated 2022-12-31
Total revenue: 7409893.16
Gross profit: -9505901.84
Operating income: -52092424.84
Net income: -43888242
Capital expenditures: 4660494
Operating cash flow: 5153336
Depreciation & amortization: 10711543
Net tangible assets: 309741215
Owner earnings: -37837193
Return on net tangible assets (%): -12.215743713667553
Buffett classification: The Gruesome
Stock price: 2.91
Shares outstanding: 4726424
Book value: 321787881
P/B ratio: 0.042742112590623015
Market cap (USD): 13753893.84
Debt to equity: 0.022552570896851146
Current ratio: 17.375434465989798
Quick ratio: 16.075985309882537
COGS to revenue (%): 228.28662485060715
SG&A to revenue (%): 575.8306237171171
Free cash flow (dilution-adjusted): -13671913
Buyback yield (%): 0
Retained earnings: -78068522
Inventory turnover: 0.8405168933471209
Receivables turnover: 2.222038913530253
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.849104912427004
FCF margin (%): -184.508908627773
Rule of 40 score: -184.508908627773
Financial ratios for EBON — annual report dated 2023-12-31
Total revenue: 4855181
Gross profit: -16703805
Operating income: -47576244
Net income: -36772143
Capital expenditures: 1108794
Operating cash flow: -11530117
Depreciation & amortization: 3519859
Net tangible assets: 277514070
Owner earnings: -34361078
Return on net tangible assets (%): -12.381742662633286
Buffett classification: The Gruesome
Stock price: 15.3
Shares outstanding: 4726424
Book value: 281322344
P/B ratio: 0.2570513460530529
Market cap (USD): 72314287.2
Debt to equity: 0.023731851174963906
Current ratio: 20.866343218794626
Quick ratio: 19.224797441648068
COGS to revenue (%): 444.0408297857485
SG&A to revenue (%): 637.1552162524939
Free cash flow (dilution-adjusted): -21648763
Buyback yield (%): 0
Retained earnings: -114840665
Inventory turnover: 1.0981160922220488
Receivables turnover: 5.129539552505299
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.618794089324393
FCF margin (%): -445.8899266577292
Revenue growth (%): -34.477044470638496
Rule of 40 score: -480.36697112836765
Financial ratios for EBON — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 254975331
Buffett classification: The Gruesome
Stock price: 5.72
Shares outstanding: 4726424
Book value: 260360398
P/B ratio: 0.10383739419541062
Market cap (USD): 27035145.279999997
Debt to equity: 0.015484612986342109
Current ratio: 19.46889931283509
Quick ratio: 18.004415741096174
Buyback yield (%): 0
Retained earnings: -135091716
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBON — annual report dated 2024-12-31
Total revenue: 5868771
Gross profit: 1189686
Operating income: -30320701
Net income: -20251051
Capital expenditures: 4923885
Operating cash flow: -17613879
Depreciation & amortization: 2601044
Net tangible assets: 254975331
Owner earnings: -22573892
Return on net tangible assets (%): -8.853363151433658
Buffett classification: The Gruesome
Stock price: 5.72
Shares outstanding: 4726424
Book value: 260360398
P/B ratio: 0.10383739419541062
Market cap (USD): 27035145.279999997
Debt to equity: 0.015484612986342109
Current ratio: 19.46889931283509
Quick ratio: 18.004415741096174
COGS to revenue (%): 79.72853260077791
SG&A to revenue (%): 537.805581441157
Free cash flow (dilution-adjusted): -21539935
Buyback yield (%): 0
Retained earnings: -135091716
Inventory turnover: 0.26955433091741227
Receivables turnover: 1.225222360752607
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.487249033516392
FCF margin (%): -367.0263331113107
Revenue growth (%): 20.876461660234703
Rule of 40 score: -346.14987145107597